THE BIOLOGIC SIGNIFICANCE OF CYTOLOGIC ATYPIA IN PROGESTOGEN-TREATED ENDOMETRIAL HYPERPLASIA

被引:175
作者
FERENCZY, A [1 ]
GELFAND, M [1 ]
机构
[1] SIR MORTIMER B DAVIS JEWISH GEN HOSP,DEPT OBSTET & GYNECOL,MONTREAL H3T 1E2,QUEBEC,CANADA
关键词
D O I
10.1016/0002-9378(89)90103-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:126 / 131
页数:6
相关论文
共 28 条
[11]  
GAL D, 1986, SEMIN ONCOL, V13, P33
[12]  
Gelfand M M, 1983, Compr Ther, V9, P12
[13]  
Gleason DF., 1985, AM SURG PATHOL, V9, P53
[14]   PRECURSORS OF CORPUS CANCER .4. ADENOMATOUS HYPERPLASIA AS STAGE O CARCINOMA OF ENDOMETRIUM [J].
GUSBERG, SB ;
KAPLAN, AL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1963, 87 (05) :662-+
[15]  
GUSBERG SB, 1974, GYNECOL ONCOL, V2, P30
[16]  
HERTIG AT, 1949, CANCER, V2, P964, DOI 10.1002/1097-0142(194911)2:6<964::AID-CNCR2820020605>3.0.CO
[17]  
2-B
[18]  
KOSS LG, 1981, OBSTET GYNECOL, V57, P681
[19]  
KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO
[20]  
2-X